COLLPLANT BIOTECHNOLOGIES LT (CLGN) Earnings History & Surprises
NASDAQ:CLGN • IL0004960188
0.569 USD
+0.02 (+4.4%)
At close: Mar 3, 2026
0.5846 USD
+0.02 (+2.74%)
Pre-Market: 3/4/2026, 8:00:02 AM
Past quarterly earnings results for COLLPLANT BIOTECHNOLOGIES LT (CLGN), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).
Earnings Snapshot
Next Earnings Date
Release DateMar 24, 2026
PeriodQ4 / 2025
EPS Estimate-$0.19
Revenue Estimate1.555M
Last Reported
Release DateNov 26, 2025
PeriodQ3 / 2025
EPS Reported-$0.27
EPS Surprise -270.78%
Revenue Surprise -98.44%
Beat Rate
0%
EPS and Revenuebeats vs estimates
Quarterly Earnings Results
EPS & Revenue History (USD)
Actual vs estimated values, surprises, q2q growth and acceleration numbers for recent quarters.
| Quarter | EPS | EPS Est | EPS Surprise | EPS Q2Q | Revenue | Revenue Est | Revenue Surprise | Revenue Q2Q |
|---|---|---|---|---|---|---|---|---|
| Q3 2025 | -0.27 | 0.16 | -270.78% | 28.95% | 77K | 4.941M | -98.44% | 1,825.00% |
| Q2 2025 | -0.28 | -0.14 | -96.08% | 24.32% | 179K | 2.595M | -93.10% | -28.11% |
| Q1 2025 | -0.13 | -0.04 | -218.63% | 64.86% | 2.055M | 2.698M | -23.83% | 1,996.94% |
| Q4 2024 | -0.34 | -0.28 | -21.21% | -41.67% | 164K | 440.64K | -62.78% | -45.15% |
| Q3 2024 | -0.38 | -0.29 | -30.72% | - | 4K | 424.32K | -99.06% | -90.70% |
| Q2 2024 | -0.37 | -0.28 | -34.35% | -175.51% | 249K | 408K | -38.97% | -97.55% |
| Q1 2024 | -0.37 | -0.36 | -3.64% | -12.12% | 98K | 612K | -83.99% | -77.37% |
| Q4 2023 | -0.24 | -0.07 | -236.13% | 36.84% | 299K | 8.735M | -96.58% | 398.33% |
| Q3 2023 | -0.38 | -0.13 | -186.58% | 5.00% | 43K | 3.566M | -98.79% | -60.91% |
| Q2 2023 | 0.49 | 0.02 | 3,102.61% | 225.64% | 10.184M | 5.255M | 93.80% | 14,448.57% |
| Q1 2023 | -0.33 | -0.30 | -11.56% | 8.33% | 433K | 245.82K | 76.15% | 518.57% |
| Q4 2022 | -0.38 | -0.32 | -18.27% | -26.67% | 60K | 51K | 17.65% | -80.65% |
| Q3 2022 | -0.40 | -0.32 | -26.50% | -37.93% | 110K | - | -21.43% | |
| Q2 2022 | -0.39 | -0.08 | -377.94% | -30.00% | 70K | 2.914M | -97.60% | -89.86% |
| Q1 2022 | -0.36 | -0.14 | -152.10% | -140.91% | 70K | 2.793M | -97.49% | -99.52% |
| Q4 2021 | -0.30 | -0.30 | -1.42% | 28.57% | 310K | - | -44.64% | |
| Q3 2021 | -0.29 | -0.29 | -1.54% | -514.29% | 140K | 125.46K | 11.59% | -96.63% |
| Q2 2021 | -0.30 | -0.10 | -194.12% | -50.00% | 690K | 3.167M | -78.21% | -15.85% |
| Q1 2021 | 0.88 | 0.52 | 70.84% | 466.67% | 14.5M | 10.26M | 41.33% | 2,277.05% |
| Q4 2020 | -0.42 | -0.31 | -37.25% | - | 560K | 290.19K | 92.98% | - |
| Q3 2020 | 0.07 | 0.94 | -92.54% | - | 4.15M | 11.966M | -65.32% | - |
| Q2 2020 | -0.20 | -0.16 | -26.50% | - | 820K | 1.57M | -47.77% | - |
| Q1 2020 | -0.24 | -0.23 | -2.30% | - | 610K | 714K | -14.57% | - |
Notes
- EPS and Revenue values are non-GAAP when available, otherwise GAAP.
- Surprise % is (Actual - Estimate) / |Estimate|. Green indicates positive surprise, red negative.
- Q2Q % is quarter-over-quarter growth. Green indicates growth, red indicates decline.
- Green right border indicates acceleration for sales or earnings growth. Acceleration is the case when the current Q2Q is above the previous Q2Q.
Earnings Q2Q Performance Trends
EPS Historical Q2Q growth and Acceleration
Revenue Historical Q2Q growth and Acceleration
Surprise distribution (Last 4 Quarters)
EPS beat statistics
EPS beat (4)
0
Average EPS beat (4)
-151.67%
Max EPS beat (4)
-21.21%
Min EPS beat (4)
-270.78%
Revenue beat statistics
Revenue beat (4)
0
Average Revenue beat (4)
-69.54%
Max Revenue beat (4)
-23.83%
Min Revenue beat (4)
-98.44%
Analysis
In the last 4 quarters, CLGN has not beaten EPS estimates in any release
CLGN has not beaten revenue estimates in any of the last 4 earnings releases
In the last 4 quarters, CLGN reported -151.7% below the EPS estimates on average.
In the last 4 quarters, CLGN reported -69.5% below the revenue estimates on average.
COLLPLANT BIOTECHNOLOGIES LT / CLGN Earnings FAQ
What is the most recent earnings date for CLGN stock?
COLLPLANT BIOTECHNOLOGIES LT (CLGN) last reported earnings on 11/26/2025.
Did CLGN stock beat earnings estimates in the most recent quarter?
COLLPLANT BIOTECHNOLOGIES LT (CLGN) missed EPS estimates and missed revenue estimates in the most recent quarter.
Can you provide information on how often COLLPLANT BIOTECHNOLOGIES LT beats earnings estimates?
In the last 4 quarters, COLLPLANT BIOTECHNOLOGIES LT (CLGN) has beaten EPS estimates in 0 out of 4 releases.